Oct 31, 2008 | Compliance, Legal, and Malpractice
Facing pressure by the Food and Drug Administration over its OvaSure test for ovarian cancer, Laboratory Corporation of America announced last Friday in a Securities and Exchange Commission filing that it had stopped sales of the test. The dispute between the FDA and the nation’s second largest laboratory company will be closely watched for insights into how the FDA regulates “home brew” assays. In the October 20, 2008 issue of The Dark Report, an intelligence briefing...
Oct 17, 2008 | Laboratory News, Laboratory Pathology
Despite the ever-growing shortage of nurses, nursing schools are turning away qualified applicants in record numbers, due to a sheer lack of space. In 2006, one in three qualified applicants was rejected. In 2007, 31,000 eligible applicants were denied entry. That number is up sharply from only 3,600 rejections in 2002. Despite what one might think from the large number of rejections, that’s only part of the story. There are additional thousands more qualified and interested applicants...
Sep 24, 2008 | Laboratory Management and Operations, Laboratory Pathology
With the theme of a “Lean Laboratory Supporting Lean Healthcare,” attendees at Lab Quality Confab this morning in Atlanta, Georgia, heard the remarkable story of Stockholm, Sweden-based St. Göran Hospital’s Lean journey to improved clinical outcomes and better customer service for its patients. This 250-bed hospital serves 21,000 inpatients and 200,000 outpatients annually. This story had added intrigue because it is healthcare delivered to the public in Sweden’s...
